Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21640651 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
Condition: Aneurysmal Subarachnoid Hemorrhage
Interventions: Drug: clazosentan;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.